Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delivering Transcutaneous Auricular Neurostimulation (tAN) to Improve Symptoms Associated With Opioid Withdrawal

NCT04075214 is registered in ClinicalTrials.gov with Spark Biomedical, Inc. as lead sponsor.

NCT NCT04075214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04075214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delivering Transcutaneous Auricular Neurostimulation (tAN) to Improve Symptoms Associated With Opioid Withdrawal
Lead sponsor
Spark Biomedical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 19, 2019
Completion date
December 14, 2020
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid withdrawal, opioid-use disorder